This second of two volumes presents the state of the art in somatostatin analogues and bombesin antagonists in neoplastic diseases. It provides a detailed description of mechanisms of action and the present clinical relevance of these new approaches in cancer treatment. Each chapter has been prepared by an expert active in the respective experimental and/or clinical field so that the reader is assured of obtaining the latest information on the topic.

This volume presents the state of the art in the use of somatostatin and LH-RH analogues in neoplastic diseases. It describes their mechanisms of action and the present clinical relevance of these approaches in cancer treatment, including structural and functional aspects. Each chapter is prepared by an expert active in the experimental and/or clinical field, so that the book comprises the most recent information on the topic.